Your browser doesn't support javascript.
loading
Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia.
Casini, Alessandro; von Mackensen, Sylvia; Santoro, Cristina; Djambas Khayat, Claudia; Belhani, Meriem; Ross, Cecil; Dorgalaleh, Akbar; Naz, Arshi; Ünal, Ekrem; Abdelwahab, Magy; Lozeron, Elise Dupuis; Trillot, Nathalie; Susen, Sophie; Peyvandi, Flora; de Moerloose, Philippe.
Affiliation
  • Casini A; Division of Angiology and Hemostasis, University Hospitals of Geneva, Geneva, Switzerland.
  • von Mackensen S; University of Geneva, Faculty of Medicine, Geneva, Switzerland.
  • Santoro C; Department of Medical Psychology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Djambas Khayat C; Hematology Division, University Hospital Policlinico Umberto I, Rome, Italy.
  • Belhani M; Hôtel-Dieu de France Hospital, Saint Joseph University, Beirut, Lebanon.
  • Ross C; Beni Messous University Hospital, Algiers, Algeria.
  • Dorgalaleh A; Department of Hematology, St John's Medical College and Hospital, Bangalore, India.
  • Naz A; Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Ünal E; National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi University of Bonn, Karachi, Pakistan.
  • Abdelwahab M; Division of Pediatric Hematology Oncology, Department of Pediatrics, Erciyes University Faculty of Medicine, Kayseri, Turkey.
  • Lozeron ED; Department of Molecular Biology and Genetic, GENKOK Stem Cell & Genome Center, Erciyes University Faculty of Medicine, Kayseri, Turkey.
  • Trillot N; Department of Pediatrics and Pediatric Hematology, Cairo University Pediatric Hospital and Social and Preventive Medicine, Cairo University, Kasr Alainy Hospital, Cairo, Egypt.
  • Susen S; Clinical Research Centre and Division of Clinical Epidemiology, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Peyvandi F; CHU Lille, Department of Hematology and Transfusion, Pôle de Biologie Pathologie Génétique, Lille, France.
  • de Moerloose P; Université Lille, INSERM, CHU Lille, Department of Hematology and Transfusion, Pôle de Biologie Pathologie Génétique, Institut Pasteur de Lille, Unité Mixte de Recherche 1011-European Genomic Institute for Diabetes (UMR1011-EGID), Lille, France; and.
Blood ; 137(22): 3127-3136, 2021 06 03.
Article in En | MEDLINE | ID: mdl-33512441
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Factor VIII / Fibrinogen / Cerebral Hemorrhage / Afibrinogenemia Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2021 Document type: Article Affiliation country: Suiza Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Factor VIII / Fibrinogen / Cerebral Hemorrhage / Afibrinogenemia Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2021 Document type: Article Affiliation country: Suiza Country of publication: Estados Unidos